Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon H Come

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfonesUpul K Bandarage, Tiansheng Wang, Jon H Come, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2020
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitorsUpul K Bandarage, John Court, Huai Gao, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2007
Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamidesB Govinda Rao, Upul K Bandarage, Tiansheng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ InhibitorsUpul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogensMegan W Tse, Meilin Zhu, Benjamin Peters, et al.
Cancer Research|June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy EfficacyAlvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogensMegan W Tse, Meilin Zhu, Benjamin Peters, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfonesUpul K Bandarage, Tiansheng Wang, Jon H Come, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2020
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitorsUpul K Bandarage, John Court, Huai Gao, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2007
Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamidesB Govinda Rao, Upul K Bandarage, Tiansheng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ InhibitorsUpul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogensMegan W Tse, Meilin Zhu, Benjamin Peters, et al.
Cancer Research|June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy EfficacyAlvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogensMegan W Tse, Meilin Zhu, Benjamin Peters, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Pageof 2